Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis

BACKGROUND: Cystic fibrosis (CF) leads to pancreatic endocrine dysfunction with progressive glycemic disturbance. Approximately 30%–50% of people with CF eventually develop CF–related diabetes (CFRD). Pre-CFRD states progress from indeterminant glycemia (INDET) to impaired fasting glucose (IFG) or i...

Descripción completa

Detalles Bibliográficos
Autores principales: Darukhanavala, Amy, Van Dessel, Filia, Ho, Jannifer, Hansen, Megan, Kremer, Ted, Alfego, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059836/
https://www.ncbi.nlm.nih.gov/pubmed/33882078
http://dx.doi.org/10.1371/journal.pone.0250036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059836/
https://www.ncbi.nlm.nih.gov/pubmed/33882078
http://dx.doi.org/10.1371/journal.pone.0250036

Ejemplares similares